{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T17:48:24Z","timestamp":1770486504625,"version":"3.49.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2015,7,3]],"date-time":"2015-07-03T00:00:00Z","timestamp":1435881600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s00228-015-1887-y","type":"journal-article","created":{"date-parts":[[2015,7,2]],"date-time":"2015-07-02T06:32:19Z","timestamp":1435818739000},"page":"1075-1082","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Developmental changes rather than repeated administration drive paracetamol glucuronidation in neonates and infants"],"prefix":"10.1007","volume":"71","author":[{"given":"Elke H. J.","family":"Krekels","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saskia","family":"van Ham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karel","family":"Allegaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"de Hoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dick","family":"Tibboel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meindert","family":"Danhof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherijne A. J.","family":"Knibbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,3]]},"reference":[{"issue":"2","key":"1887_CR1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/jama.2012.148050","volume":"309","author":"I Ceelie","year":"2013","unstructured":"Ceelie I, de Wildt SN, van Dijk M, van den Berg MM, van den Bosch GE, Duivenvoorden HJ, de Leeuw TG, Math\u00f4t R, Knibbe CA, Tibboel D (2013) Effect of intravenous paracetamol on postoperative morphine requirements in neonates and infants undergoing major noncardiac surgery: a randomized controlled trial. JAMA 309(2):149\u201354","journal-title":"JAMA"},{"issue":"6","key":"1887_CR2","doi-asserted-by":"crossref","first-page":"e1618","DOI":"10.1542\/peds.2011-0359","volume":"128","author":"C Hammerman","year":"2011","unstructured":"Hammerman C, Bin-Nun A, Markovitch E, Schimmel MS, Kaplan M, Fink D (2011) Ductal closure with paracetamol: a surprising new approach to patent ductus arteriosus treatment. Pediatrics 128(6):e1618\u201321","journal-title":"Pediatrics"},{"issue":"1","key":"1887_CR3","doi-asserted-by":"crossref","first-page":"F94","DOI":"10.1136\/archdischild-2012-302044","volume":"98","author":"MY Oncel","year":"2013","unstructured":"Oncel MY, Yurttutan S, Uras N, Altug N, Ozdemir R, Ekmen S, Erdeve O, Dilmen U (2013) An alternative drug (paracetamol) in the management of patent ductus arteriosus in ibuprofen-resistant or contraindicated preterm infants. Arch Dis Child Fetal Neonatal Ed 98(1):F94","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"11","key":"1887_CR4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077888","volume":"8","author":"D Dang","year":"2013","unstructured":"Dang D, Wang D, Zhang C, Zhou W, Zhou Q, Wu H (2013) Comparison of oral paracetamol versus ibuprofen in premature infants with patent ductus arteriosus: a randomized controlled trial. PLoS One 8(11), e77888","journal-title":"PLoS One"},{"issue":"12","key":"1887_CR5","doi-asserted-by":"crossref","first-page":"959","DOI":"10.2165\/00003088-200241120-00003","volume":"41","author":"J Alcorn","year":"2002","unstructured":"Alcorn J, McNamara PJ (2002) Ontogeny of hepatic and renal systemic clearance pathways in infants: part I. Clin Pharmacokinet 41(12):959\u201398","journal-title":"Clin Pharmacokinet"},{"issue":"6","key":"1887_CR6","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/sj.clpt.6100121","volume":"81","author":"CK Gelotte","year":"2007","unstructured":"Gelotte CK, Auiler JF, Lynch JM, Temple AR, Slattery JT (2007) Disposition of acetaminophen at 4, 6, and 8 g\/day for 3 days in healthy young adults. Clin Pharmacol Ther 81(6):840\u20138","journal-title":"Clin Pharmacol Ther"},{"issue":"9","key":"1887_CR7","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/j.1651-2227.2005.tb02088.x","volume":"94","author":"K Allegaert","year":"2005","unstructured":"Allegaert K, de Hoon J, Verbesselt R, Vanhole C, Devlieger H, Tibboel D (2005) Intra- and interindividual variability of glucuronidation of paracetamol during repeated administration of propacetamol in neonates. Acta Paediatr 94(9):1273\u20139","journal-title":"Acta Paediatr"},{"issue":"4","key":"1887_CR8","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1358\/mf.2007.29.4.1106408","volume":"29","author":"K Allegaert","year":"2007","unstructured":"Allegaert K, Verbesselt R, Rayyan M, Debeer A, de Hoon J (2007) Urinary metabolites to assess in vivo ontogeny of hepatic drug metabolism in early neonatal life. Methods Find Exp Clin Pharmacol 29(4):251\u20136","journal-title":"Methods Find Exp Clin Pharmacol"},{"issue":"Suppl 1","key":"1887_CR9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00228-009-0782-9","volume":"67","author":"RF Cock De","year":"2011","unstructured":"De Cock RF, Piana C, Krekels EH, Danhof M, Allegaert K, Knibbe CA (2011) The role of population PK-PD modelling in paediatric clinical research. Eur J Clin Pharmacol 67(Suppl 1):5\u201316","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"1887_CR10","doi-asserted-by":"crossref","first-page":"F25","DOI":"10.1136\/fn.89.1.F25","volume":"89","author":"K Allegaert","year":"2004","unstructured":"Allegaert K, Van der Marel CD, Debeer A, Pluim MA, Van Lingen RA, Vanhole C, Tibboel D, Devlieger H (2004) Pharmacokinetics of single dose intravenous propacetamol in neonates: effect of gestational age. Arch Dis Child Fetal Neonatal Ed 89(1):F25\u20138","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"3","key":"1887_CR11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00228-004-0756-x","volume":"60","author":"K Allegaert","year":"2004","unstructured":"Allegaert K, Anderson BJ, Naulaers G, de Hoon J, Verbesselt R, Debeer A, Devlieger H, Tibboel D (2004) Intravenous paracetamol (propacetamol) pharmacokinetics in term and preterm neonates. Eur J Clin Pharmacol 60(3):191\u20137","journal-title":"Eur J Clin Pharmacol"},{"key":"1887_CR12","unstructured":"Fisher DM. PLT Tools, available at: http:\/\/www.pltsoft.com"},{"issue":"3","key":"1887_CR13","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.1365-2125.2012.04402.x","volume":"75","author":"A Kulo","year":"2013","unstructured":"Kulo A, Peeters MY, Allegaert K, Smits A, de Hoon J, Verbesselt R, Lewi L, van de Velde M, Knibbe CA (2013) Pharmacokinetics of paracetamol and its metabolites in women at delivery and post-partum. Br J Clin Pharmacol 75(3):850\u201360","journal-title":"Br J Clin Pharmacol"},{"key":"1887_CR14","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S0022-3565(25)30450-7","volume":"196","author":"DT Lowenthal","year":"1976","unstructured":"Lowenthal DT, Oie S, Van Stone JC, Briggs WA, Levy G (1976) Pharmacokinetics of acetaminophen elimination by anephric patients. J Pharmacol Exp Ther 196:570\u2013578","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"1887_CR15","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.cmpb.2007.12.002","volume":"90","author":"E Comets","year":"2008","unstructured":"Comets E, Brendel K, Mentr\u00e9 F (2008) Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: the npde add-on package for R. Comput Methods Prog Biomed 90(2):154\u201366","journal-title":"Comput Methods Prog Biomed"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-015-1887-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-015-1887-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-015-1887-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:02:29Z","timestamp":1748476949000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-015-1887-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,3]]},"references-count":15,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["1887"],"URL":"https:\/\/doi.org\/10.1007\/s00228-015-1887-y","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,3]]}}}